GC
CPXX

Guggenheim Capital’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Guggenheim Capital’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,737
Closed -$294K – 2988
2016
Q2 		$294K Buy
+9,737
New +$198K ﹤0.01% 2551

Guggenheim Capital's CPXX Position: Q3 2016 in Review

Guggenheim Capital sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 9,737 shares — an estimated $294K sold.

Guggenheim Capital first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $294K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Guggenheim Capital reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Guggenheim Capital sold 9,737 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $294K.
  • Guggenheim Capital first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Guggenheim Capital's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $294K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Guggenheim Capital's 13F filing for Q3 2016, filed 15 Nov 2016.